Loading stock…

Sempra (SRE) Stock Verdict & Ratings | Investment Bastion

02Growth

Is it actually growing, and how fast?

SRESempra

Revenue FY25$13.7B

GROWTH RATING↗

VERY WEAK10 / 100

REVENUE GROWTH▾SCORE

Revenue, last 3Y, CAGR-2%2

Revenue, next 1Y+1%3

Revenue, next 3Y, CAGR-1%1

Revenue, next 5Y, CAGR+2%2

EARNINGS FORECAST▾SCORE

EPS growth, FY26E+87%10

EPS growth, FY27E+9%6

EPS growth, FY28E+8%6

GROWTH ASSESSMENT

STRENGTHS

Earnings are set to grow faster than sales (EPS about 9%/yr vs revenue -1%/yr), so margins should widen.

WATCH

None flagged.

WEAKNESSES

Growth is the weak spot here, trailing 90% of companies worldwide.

Revenue fell 2%/yr over the last 3 years, behind 80% of companies worldwide.2/10

Revenue is set to shrink 1%/yr over the next 3 years, behind most of the market.2/10

Revenue fell 2%/yr over the last 3 years and is set to keep shrinking around 1%/yr.

Over five years revenue is set to grow 2%/yr, behind 80% of companies worldwide.2/10

BOTTOM LINE

Stalled Business

Growth is a weak point here: a business that is still shrinking. The one thing to watch: revenue has shrunk over the past 3 years.

03Price Momentum

Is the market behind it right now?

MOMENTUM RATING↗

WEAK26 / 100

SHORT-TERM RETURNS▾SCORE

1-month return-4%5

3-month return-15%2

YTD return-7%4

MID & LONG-TERM▾SCORE

% of 52-week high80%5

1-year return-12%3

3-year return+31%4

5-year return+49%6

MOMENTUM ASSESSMENT

STRENGTHS

None flagged.

WATCH

Average long-term results. Multi-year returns are middling (+31% over three years and +49% over five), roughly average for the market.

It's down 12% over the past year, now 20% below its 52-week high. That is a touch behind the market.

Returns sit at the market level over the past month (-4%) and so far this year (-7%).

WEAKNESSES

The stock is underperforming over three months (-15%).

BOTTOM LINE

Falling Knife

Returns rank poorly over both the short and long run, and the price is still falling. Momentum is firmly negative — catching this is a bet against the tape, not with it. Wait for a base to form. The one thing to watch: the stock is underperforming over three months.

04Value

Are you paying a fair price for it?

Stop guessing on Sempra. Get the full investment case.

Premium

$20.75/month

Billed annually at $249/year $348

✓
Stock VerdictValuation and investment strategy for 4,000+ stocks. Days of hedge fund analyst research, done in 2 minutes.
✓
RadarFind your next investment idea: top-ranked stocks across all 9 Bastion strategies.
✓
Portfolio ManagerCheck if Bastion algorithms added the stock you care about to their portfolios.

Secure via Stripe

Trusted by 1,000+ investors in our community

Loading charts…

02Growth

Is it actually growing, and how fast?

SRESempra

Revenue FY25$13.7B

GROWTH RATING↗

VERY WEAK10 / 100

REVENUE GROWTH▾SCORE

Revenue, last 3Y, CAGR-2%2

Revenue, next 1Y+1%3

Revenue, next 3Y, CAGR-1%1

Revenue, next 5Y, CAGR+2%2

EARNINGS FORECAST▾SCORE

EPS growth, FY26E+87%10

EPS growth, FY27E+9%6

EPS growth, FY28E+8%6

GROWTH ASSESSMENT

STRENGTHS

Earnings are set to grow faster than sales (EPS about 9%/yr vs revenue -1%/yr), so margins should widen.

WATCH

None flagged.

WEAKNESSES

Growth is the weak spot here, trailing 90% of companies worldwide.

Revenue fell 2%/yr over the last 3 years, behind 80% of companies worldwide.2/10

Revenue is set to shrink 1%/yr over the next 3 years, behind most of the market.2/10

Revenue fell 2%/yr over the last 3 years and is set to keep shrinking around 1%/yr.

Over five years revenue is set to grow 2%/yr, behind 80% of companies worldwide.2/10

BOTTOM LINE

Stalled Business

Growth is a weak point here: a business that is still shrinking. The one thing to watch: revenue has shrunk over the past 3 years.

03Price Momentum

Is the market behind it right now?

MOMENTUM RATING↗

WEAK26 / 100

SHORT-TERM RETURNS▾SCORE

1-month return-4%5

3-month return-15%2

YTD return-7%4

MID & LONG-TERM▾SCORE

% of 52-week high80%5

1-year return-12%3

3-year return+31%4

5-year return+49%6

MOMENTUM ASSESSMENT

STRENGTHS

None flagged.

WATCH

Average long-term results. Multi-year returns are middling (+31% over three years and +49% over five), roughly average for the market.

It's down 12% over the past year, now 20% below its 52-week high. That is a touch behind the market.

Returns sit at the market level over the past month (-4%) and so far this year (-7%).

WEAKNESSES

The stock is underperforming over three months (-15%).

BOTTOM LINE

Falling Knife

04Value

Are you paying a fair price for it?

Stop guessing on Sempra. Get the full investment case.

Premium

$20.75/month

Billed annually at $249/year $348

✓
Stock VerdictValuation and investment strategy for 4,000+ stocks. Days of hedge fund analyst research, done in 2 minutes.
✓
RadarFind your next investment idea: top-ranked stocks across all 9 Bastion strategies.
✓
Portfolio ManagerCheck if Bastion algorithms added the stock you care about to their portfolios.

Secure via Stripe

Trusted by 1,000+ investors in our community

Sempra

01Key Ratings

02Growth

03Price Momentum

04Value

Stop guessing on Sempra. Get the full investment case.

Premium

02Growth

03Price Momentum

04Value

Stop guessing on Sempra. Get the full investment case.

Premium